Inhibition of melanoma brain metastasis by targeting melanotransferrin at the cell surface

Area of Science:

• Oncology
• Neuroscience
• Immunology

Background:

• Malignant melanoma frequently metastasizes to the brain, leading to a poor prognosis.
• Melanotransferrin (MTf), a cell surface antigen on melanoma, is implicated in promoting cancer cell invasion.

Purpose of the Study:

• To investigate the role of membrane-bound MTf in the development of melanoma brain metastasis.
• To evaluate the therapeutic potential of anti-MTf monoclonal antibodies (mAbs) in preventing brain metastasis.

Main Methods:

• Utilized a xenograft model with human melanoma SK-Mel 28 cells in nude mice.
• Administered a monoclonal antibody (L235) targeting human MTf.
• Assessed melanoma cell transmigration across the blood-brain barrier (BBB) in vitro correlated with MTf expression.

Main Results:

• MTf-positive melanoma cells were detected in the brains of mice.
• A single dose of anti-MTf mAb (L235) significantly reduced brain metastasis.
• In vitro, melanoma cell ability to cross the BBB correlated with cell surface MTf levels.

Conclusions:

• Membrane-bound MTf is crucial for melanoma cell transmigration across the BBB and subsequent brain metastasis.
• MTf represents a promising therapeutic target for preventing melanoma brain metastasis.
• Anti-MTf mAb therapy demonstrates significant potential in preclinical models for treating or preventing metastatic melanoma.